Molecular Basis for Endothelial Lumen Formation and Tubulogenesis During Vasculogenesis and Angiogenic Sprouting

International Review of Cell and Molecular Biology

Volumn 288, Issue , 2011, Pages 101-165

  Davis, George E ^a   Stratman, Amber N ^a   Sacharidou, Anastasia ^a   Koh, Wonshill ^a  

^a University of Missouri   (United States)

Author keywords

Cdc42; Collagen; Endothelial lumen formation; Extracellular matrix; Integrins; MT1 MMP; Pericytes; Rho GTPases; Tubulogenesis; Vascular basement membrane matrix assembly; Vascular guidance tunnels

Indexed keywords

ADAM PROTEIN; INTERSTITIAL COLLAGENASE; MATRIX METALLOPROTEINASE 14; P21 ACTIVATED KINASE 2; P21 ACTIVATED KINASE 4; PROTEIN CDC42; STEROID RECEPTOR COACTIVATOR 1; STROMELYSIN 2; TISSUE INHIBITOR OF METALLOPROTEINASE 3;

ANGIOGENESIS; BOOK; CELL ADHESION; CELL DIFFERENTIATION; CELL INTERACTION; CELL MOTILITY; CELL POLARITY; DOUBLE LUMEN TUBE; ENDOTHELIUM; ENDOTHELIUM CELL; EXTRACELLULAR MATRIX; HUMAN; MICROCIRCULATION; MOLECULAR INTERACTION; MORPHOGENESIS; NERVE SPROUTING; NONHUMAN; PERICYTE; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

EID: 79953800449     PISSN: 19376448     EISSN: None     Source Type: Book Series    
DOI: 10.1016/B978-0-12-386041-5.00003-0     Document Type: Chapter

References (220)

1. Adams R.H., Alitalo K. Molecular regulation of angiogenesis and lymphangiogenesis. Nat. Rev. Mol. Cell Biol. 2007, 8:464-478.
2. Alajati A., Laib A.M., Weber H., Boos A.M., Bartol A., Ikenberg K., et al. Spheroid-based engineering of a human vasculature in mice. Nat. Methods 2008, 5:439-445.
3. Alavi A., Hood J.D., Frausto R., Stupack D.G., Cheresh D.A. Role of Raf in vascular protection from distinct apoptotic stimuli. Science 2003, 301:94-96.
4. Aplin A.C., Fogel E., Zorzi P., Nicosia R.F. The aortic ring model of angiogenesis. Methods Enzymol. 2008, 443:119-136.
5. Apte S.S. A disintegrin-like and metalloprotease (reprolysin-type) with thrombospondin type 1 motif (ADAMTS) superfamily: functions and mechanisms. J. Biol. Chem. 2009, 284:31493-31497.
6. Armulik A., Abramsson A., Betsholtz C. Endothelial/pericyte interactions. Circ. Res. 2005, 97:512-523.
7. Armulik A., Genove G., Mae M., Nisancioglu M.H., Wallgard E., Niaudet C., et al. Pericytes regulate the blood-brain barrier. Nature 2010, 468:557-561.
8. Arroyo A.G., Iruela-Arispe M.L. Extracellular matrix, inflammation, and the angiogenic response. Cardiovasc. Res. 2010, 86:226-235.
9. Astrof S., Crowley D., Hynes R.O. Multiple cardiovascular defects caused by the absence of alternatively spliced segments of fibronectin. Dev. Biol. 2007, 311:11-24.
10. Baker A.H., Edwards D.R., Murphy G. Metalloproteinase inhibitors: biological actions and therapeutic opportunities. J. Cell Sci. 2002, 115:3719-3727.
11. Bayless K.J., Davis G.E. The Cdc42 and Rac1 GTPases are required for capillary lumen formation in three-dimensional extracellular matrices. J. Cell Sci. 2002, 115:1123-1136.
12. Bayless K.J., Davis G.E. Sphingosine-1-phosphate markedly induces matrix metalloproteinase and integrin-dependent human endothelial cell invasion and lumen formation in three-dimensional collagen and fibrin matrices. Biochem. Biophys. Res. Commun. 2003, 312:903-913.
13. Bayless K.J., Davis G.E. Microtubule depolymerization rapidly collapses capillary tube networks in vitro and angiogenic vessels in vivo through the small GTPase Rho. J. Biol. Chem. 2004, 279:11686-11695.
14. Bayless K.J., Salazar R., Davis G.E. RGD-dependent vacuolation and lumen formation observed during endothelial cell morphogenesis in three-dimensional fibrin matrices involves the alpha(v)beta(3) and alpha(5)beta(1) integrins. Am. J. Pathol. 2000, 156:1673-1683.
15. Bayless K.J., Kwak H.I., Su S.C. Investigating endothelial invasion and sprouting behavior in three-dimensional collagen matrices. Nat. Protoc. 2009, 4:1888-1898.
16. Bell S.E., Mavila A., Salazar R., Bayless K.J., Kanagala S., Maxwell S.A., et al. Differential gene expression during capillary morphogenesis in 3D collagen matrices: regulated expression of genes involved in basement membrane matrix assembly, cell cycle progression, cellular differentiation and G-protein signaling. J. Cell Sci. 2001, 114:2755-2773.
17. Benedito R., Trindade A., Hirashima M., Henrique D., da Costa L.L., Rossant J., et al. Loss of Notch signalling induced by Dll4 causes arterial calibre reduction by increasing endothelial cell response to angiogenic stimuli. BMC Dev. Biol. 2008, 8:117.
18. Benjamin L.E., Hemo I., Keshet E. A plasticity window for blood vessel remodelling is defined by pericyte coverage of the preformed endothelial network and is regulated by PDGF-B and VEGF. Development 1998, 125:1591-1598.
19. Benjamin L.E., Golijanin D., Itin A., Pode D., Keshet E. Selective ablation of immature blood vessels in established human tumors follows vascular endothelial growth factor withdrawal. J. Clin. Invest. 1999, 103:159-165.
20. Bergers G., Song S., Meyer-Morse N., Bergsland E., Hanahan D. Benefits of targeting both pericytes and endothelial cells in the tumor vasculature with kinase inhibitors. J. Clin. Invest. 2003, 111:1287-1295.
21. Bjarnegard M., Enge M., Norlin J., Gustafsdottir S., Fredriksson S., Abramsson A., et al. Endothelium-specific ablation of PDGFB leads to pericyte loss and glomerular, cardiac and placental abnormalities. Development 2004, 131:1847-1857.
22. Blobel C.P. ADAMs: key components in EGFR signalling and development. Nat. Rev. Mol. Cell Biol. 2005, 6:32-43.
23. Blobel C.P. 3D trumps 2D when studying endothelial cells. Blood 2010, 115:5128-5130.
24. Blum Y., Belting H.G., Ellertsdottir E., Herwig L., Luders F., Affolter M. Complex cell rearrangements during intersegmental vessel sprouting and vessel fusion in the zebrafish embryo. Dev. Biol. 2008, 316:312-322.
25. Bokoch G.M. Biology of the p21-activated kinases. Annu. Rev. Biochem. 2003, 72:743-781.
26. Brazil D.P., Hemmings B.A. Cell polarity: scaffold proteins par excellence. Curr. Biol. 2000, 10:R592-R594.
27. Brew K., Nagase H. The tissue inhibitors of metalloproteinases (TIMPs): an ancient family with structural and functional diversity. Biochim. Biophys. Acta 2010, 1803:55-71.
28. Bryan B.A., D'Amore P.A. Pericyte isolation and use in endothelial/pericyte coculture models. Methods Enzymol. 2008, 443:315-331.
29. Bryant D.M., Mostov K.E. From cells to organs: building polarized tissue. Nat. Rev. Mol. Cell Biol. 2008, 9:887-901.
30. Bryant D.M., Datta A., Rodriguez-Fraticelli A.E., Peranen J., Martin-Belmonte F., Mostov K.E. A molecular network for de novo generation of the apical surface and lumen. Nat. Cell Biol. 2010, 12:1035-1045.
31. Carmeliet P. Angiogenesis in life, disease and medicine. Nature 2005, 438:932-936.
32. Chang S., Young B.D., Li S., Qi X., Richardson J.A., Olson E.N. Histone deacetylase 7 maintains vascular integrity by repressing matrix metalloproteinase 10. Cell 2006, 126:321-334.
33. Chappell J.C., Bautch V.L. Vascular development: genetic mechanisms and links to vascular disease. Curr. Top. Dev. Biol. 2010, 90:43-72.
34. Chun T.H., Sabeh F., Ota I., Murphy H., McDonagh K.T., Holmbeck K., et al. MT1-MMP-dependent neovessel formation within the confines of the three-dimensional extracellular matrix. J. Cell Biol. 2004, 167:757-767.
35. Chung L., Dinakarpandian D., Yoshida N., Lauer-Fields J.L., Fields G.B., Visse R., et al. Collagenase unwinds triple-helical collagen prior to peptide bond hydrolysis. EMBO J. 2004, 23:3020-3030.
36. Corada M., Chimenti S., Cera M.R., Vinci M., Salio M., Fiordaliso F., et al. Junctional adhesion molecule-A-deficient polymorphonuclear cells show reduced diapedesis in peritonitis and heart ischemia-reperfusion injury. Proc. Natl. Acad. Sci. USA 2005, 102:10634-10639.
37. Crosby C.V., Fleming P.A., Argraves W.S., Corada M., Zanetta L., Dejana E., et al. VE-cadherin is not required for the formation of nascent blood vessels but acts to prevent their disassembly. Blood 2005, 105:2771-2776.
38. Culver J.C., Dickinson M.E. The effects of hemodynamic force on embryonic development. Microcirculation 2010, 17:164-178.
39. Daneman R., Zhou L., Kebede A.A., Barres B.A. Pericytes are required for blood-brain barrier integrity during embryogenesis. Nature 2010, 468:562-566.
40. Davis G.E. Matricryptic sites control tissue injury responses in the cardiovascular system: relationships to pattern recognition receptor regulated events. J. Mol. Cell Cardiol. 2010, 48:454-460.
41. Davis G.E., Bayless K.J. An integrin and Rho GTPase-dependent pinocytic vacuole mechanism controls capillary lumen formation in collagen and fibrin matrices. Microcirculation 2003, 10:27-44.
42. Davis G.E., Camarillo C.W. An alpha 2 beta 1 integrin-dependent pinocytic mechanism involving intracellular vacuole formation and coalescence regulates capillary lumen and tube formation in three-dimensional collagen matrix. Exp. Cell Res. 1996, 224:39-51.
43. Davis G.E., Saunders W.B. Molecular balance of capillary tube formation versus regression in wound repair: role of matrix metalloproteinases and their inhibitors. J. Investig. Dermatol. Symp. Proc. 2006, 11:44-56.
44. Davis G.E., Senger D.R. Endothelial extracellular matrix: biosynthesis, remodeling, and functions during vascular morphogenesis and neovessel stabilization. Circ. Res. 2005, 97:1093-1107.
45. Davis G.E., Senger D.R. Extracellular matrix mediates a molecular balance between vascular morphogenesis and regression. Curr. Opin. Hematol. 2008, 15:197-203.
46. Davis G.E., Bayless K.J., Davis M.J., Meininger G.A. Regulation of tissue injury responses by the exposure of matricryptic sites within extracellular matrix molecules. Am. J. Pathol. 2000, 156:1489-1498.
47. Davis G.E., Pintar Allen K.A., Salazar R., Maxwell S.A. Matrix metalloproteinase-1 and -9 activation by plasmin regulates a novel endothelial cell-mediated mechanism of collagen gel contraction and capillary tube regression in three-dimensional collagen matrices. J. Cell Sci. 2001, 114:917-930.
48. Davis G.E., Bayless K.J., Mavila A. Molecular basis of endothelial cell morphogenesis in three-dimensional extracellular matrices. Anat. Rec. 2002, 268:252-275.
49. Davis G.E., Koh W., Stratman A.N. Mechanisms controlling human endothelial lumen formation and tube assembly in three-dimensional extracellular matrices. Birth Defects Res. C Embryo Today 2007, 81:270-285.
50. Dejana E., Tournier-Lasserve E., Weinstein B.M. The control of vascular integrity by endothelial cell junctions: molecular basis and pathological implications. Dev. Cell 2009, 16:209-221.
51. Dekan G., Miettinen A., Schnabel E., Farquhar M.G. Binding of monoclonal antibodies to glomerular endothelium, slit membranes, and epithelium after in vivo injection. Localization of antigens and bound IgGs by immunoelectron microscopy. Am. J. Pathol. 1990, 137:913-927.
52. Del Toro R., Prahst C., Mathivet T., Siegfried G., Kaminker J.S., Larrivee B., et al. Identification and functional analysis of endothelial tip cell-enriched genes. Blood 2010, 116:4025-4033.
53. Devine W.P., Lubarsky B., Shaw K., Luschnig S., Messina L., Krasnow M.A. Requirement for chitin biosynthesis in epithelial tube morphogenesis. Proc. Natl. Acad. Sci. USA 2005, 102:17014-17019.
54. Drake C.J. Embryonic and adult vasculogenesis. Birth Defects Res. C Embryo Today 2003, 69:73-82.
55. Drake C.J., Davis L.A., Little C.D. Antibodies to beta 1-integrins cause alterations of aortic vasculogenesis, in vivo. Dev. Dyn. 1992, 193:83-91.
56. Ebnet K., Aurrand-Lions M., Kuhn A., Kiefer F., Butz S., Zander K., et al. The junctional adhesion molecule (JAM) family members JAM-2 and JAM-3 associate with the cell polarity protein PAR-3: a possible role for JAMs in endothelial cell polarity. J. Cell Sci. 2003, 116:3879-3891.
57. Ebnet K., Suzuki A., Ohno S., Vestweber D. Junctional adhesion molecules (JAMs): more molecules with dual functions?. J. Cell Sci. 2004, 117:19-29.
58. Edwards D.R., Handsley M.M., Pennington C.J. The ADAM metalloproteinases. Mol. Aspects Med. 2008, 29:258-289.
59. Egginton S., Gerritsen M. Lumen formation: in vivo versus in vitro observations. Microcirculation 2003, 10:45-61.
60. Etienne-Manneville S. Cdc42-the centre of polarity. J. Cell Sci. 2004, 117:1291-1300.
61. Etienne-Manneville S., Hall A. Cdc42 regulates GSK-3beta and adenomatous polyposis coli to control cell polarity. Nature 2003, 421:753-756.
62. Filla M.B., Czirok A., Zamir E.A., Little C.D., Cheuvront T.J., Rongish B.J. Dynamic imaging of cell, extracellular matrix, and tissue movements during avian vertebral axis patterning. Birth Defects Res. C Embryo Today 2004, 72:267-276.
63. Fisher K.E., Pop A., Koh W., Anthis N.J., Saunders W.B., Davis G.E. Tumor cell invasion of collagen matrices requires coordinate lipid agonist-induced G-protein and membrane-type matrix metalloproteinase-1-dependent signaling. Mol. Cancer 2006, 5:69.
64. Fisher K.E., Sacharidou A., Stratman A.N., Mayo A.M., Fisher S.B., Mahan R.D., et al. MT1-MMP- and Cdc42-dependent signaling co-regulate cell invasion and tunnel formation in 3D collagen matrices. J. Cell Sci. 2009, 122:4558-4569.
65. Folkman J., Haudenschild C. Angiogenesis in vitro. Nature 1980, 288:551-556.
66. Foo S.S., Turner C.J., Adams S., Compagni A., Aubyn D., Kogata N., et al. Ephrin-B2 controls cell motility and adhesion during blood-vessel-wall assembly. Cell 2006, 124:161-173.
67. Francis S.E., Goh K.L., Hodivala-Dilke K., Bader B.L., Stark M., Davidson D., et al. Central roles of alpha5beta1 integrin and fibronectin in vascular development in mouse embryos and embryoid bodies. Arterioscler. Thromb. Vasc. Biol. 2002, 22:927-933.
68. Gaengel K., Genove G., Armulik A., Betsholtz C. Endothelial-mural cell signaling in vascular development and angiogenesis. Arterioscler. Thromb. Vasc. Biol. 2009, 29:630-638.
69. Galabova-Kovacs G., Matzen D., Piazzolla D., Meissl K., Plyushch T., Chen A.P., et al. Essential role of B-Raf in ERK activation during extraembryonic development. Proc. Natl. Acad. Sci. USA 2006, 103:1325-1330.
70. Galan Moya E.M., Le Guelte A., Gavard J. PAKing up to the endothelium. Cell. Signal. 2009, 21:1727-1737.
71. Gassama-Diagne A., Yu W., ter Beest M., Martin-Belmonte F., Kierbel A., Engel J., et al. Phosphatidylinositol-3,4,5-trisphosphate regulates the formation of the basolateral plasma membrane in epithelial cells. Nat. Cell Biol. 2006, 8:963-970.
72. Gerhardt H., Golding M., Fruttiger M., Ruhrberg C., Lundkvist A., Abramsson A., et al. VEGF guides angiogenic sprouting utilizing endothelial tip cell filopodia. J. Cell Biol. 2003, 161:1163-1177.
73. Germain S., Monnot C., Muller L., Eichmann A. Hypoxia-driven angiogenesis: role of tip cells and extracellular matrix scaffolding. Curr. Opin. Hematol. 2010, 17:245-251.
74. Gill S.E., Parks W.C. Metalloproteinases and their inhibitors: regulators of wound healing. Int. J. Biochem. Cell Biol. 2008, 40:1334-1347.
75. Gomes E.R., Jani S., Gundersen G.G. Nuclear movement regulated by Cdc42, MRCK, myosin, and actin flow establishes MTOC polarization in migrating cells. Cell 2005, 121:451-463.
76. Gonzalo P., Guadamillas M.C., Hernandez-Riquer M.V., Pollan A., Grande-Garcia A., Bartolome R.A., et al. MT1-MMP is required for myeloid cell fusion via regulation of Rac1 signaling. Dev. Cell 2010, 18:77-89.
77. Gore A.V., Lampugnani M.G., Dye L., Dejana E., Weinstein B.M. Combinatorial interaction between CCM pathway genes precipitates hemorrhagic stroke. Dis. Model Mech. 2008, 1:275-281.
78. Greenberg J.I., Shields D.J., Barillas S.G., Acevedo L.M., Murphy E., Huang J., et al. A role for VEGF as a negative regulator of pericyte function and vessel maturation. Nature 2008, 456:809-813.
79. Greene A.S., Tonellato P.J., Lui J., Lombard J.H., Cowley A.W. Microvascular rarefaction and tissue vascular resistance in hypertension. Am. J. Physiol. 1989, 256:H126-H131.
80. Gridley T. Notch signaling in the vasculature. Curr. Top. Dev. Biol. 2010, 92:277-309.
81. Haas T.L., Stitelman D., Davis S.J., Apte S.S., Madri J.A. Egr-1 mediates extracellular matrix-driven transcription of membrane type 1 matrix metalloproteinase in endothelium. J. Biol. Chem. 1999, 274:22679-22685.
82. Hall A. Rho GTPases and the control of cell behaviour. Biochem. Soc. Trans. 2005, 33:891-895.
83. Ham C., Levkau B., Raines E.W., Herren B. ADAM15 is an adherens junction molecule whose surface expression can be driven by VE-cadherin. Exp. Cell Res. 2002, 279:239-247.
84. Hammes H.P. Pericytes and the pathogenesis of diabetic retinopathy. Horm. Metab. Res. 2005, 37(Suppl. 1):39-43.
85. Handsley M.M., Edwards D.R. Metalloproteinases and their inhibitors in tumor angiogenesis. Int. J. Cancer 2005, 115:849-860.
86. Hao Y., Du Q., Chen X., Zheng Z., Balsbaugh J.L., Maitra S., et al. Par3 controls epithelial spindle orientation by aPKC-mediated phosphorylation of apical pins. Curr. Biol. 2010, 20:1809-1818.
87. Harris E.S., Nelson W.J. VE-cadherin: at the front, center, and sides of endothelial cell organization and function. Curr. Opin. Cell Biol. 2010, 22:651-658.
88. Hartmann D., de Strooper B., Serneels L., Craessaerts K., Herreman A., Annaert W., et al. The disintegrin/metalloprotease ADAM 10 is essential for Notch signalling but not for alpha-secretase activity in fibroblasts. Hum. Mol. Genet. 2002, 11:2615-2624.
89. Hellstrom M., Phng L.K., Hofmann J.J., Wallgard E., Coultas L., Lindblom P., et al. Dll4 signalling through Notch1 regulates formation of tip cells during angiogenesis. Nature 2007, 445:776-780.
90. Herbert S.P., Huisken J., Kim T.N., Feldman M.E., Houseman B.T., Wang R.A., et al. Arterial-venous segregation by selective cell sprouting: an alternative mode of blood vessel formation. Science 2009, 326:294-298.
91. Hill M.A., Sun Z., Martinez-Lemus L., Meininger G.A. New technologies for dissecting the arteriolar myogenic response. Trends Pharmacol. Sci. 2007, 28:308-315.
92. Hirschi K.K., Rohovsky S.A., D'Amore P.A. PDGF, TGF-beta, and heterotypic cell-cell interactions mediate endothelial cell-induced recruitment of 10T1/2 cells and their differentiation to a smooth muscle fate. J. Cell Biol. 1998, 141:805-814.
93. Hoang M.V., Smith L.E., Senger D.R. Moderate GSK-3beta inhibition improves neovascular architecture, reduces vascular leakage, and reduces retinal hypoxia in a model of ischemic retinopathy. Angiogenesis 2010, 13:269-277.
94. Hoang M.V., Nagy J.A., Senger D.R. Active Rac1 improves pathological VEGF neovessel architecture and reduces vascular leak: mechanistic similarities with angiopoietin-1. Blood 2010, 117:1751-1760.
95. Hoang M.V., Nagy J.A., Senger D.R. Cdc42-mediated inhibition of GSK-3beta improves angio-architecture and lumen formation during VEGF-driven pathological angiogenesis. Microvasc. Res. 2010, 81:34-43.
96. Holderfield M.T., Hughes C.C. Crosstalk between vascular endothelial growth factor, notch, and transforming growth factor-beta in vascular morphogenesis. Circ. Res. 2008, 102:637-652.
97. Horiuchi K., Weskamp G., Lum L., Hammes H.P., Cai H., Brodie T.A., et al. Potential role for ADAM15 in pathological neovascularization in mice. Mol. Cell. Biol. 2003, 23:5614-5624.
98. Howson K.M., Aplin A.C., Gelati M., Alessandri G., Parati E.A., Nicosia R.F. The postnatal rat aorta contains pericyte progenitor cells that form spheroidal colonies in suspension culture. Am. J. Physiol. Cell Physiol. 2005, 289:C1396-C1407.
99. Hughes C.C. Endothelial-stromal interactions in angiogenesis. Curr. Opin. Hematol. 2008, 15:204-209.
100. Hynes R.O. Cell-matrix adhesion in vascular development. J. Thromb. Haemost. 2007, 5(Suppl. 1):32-40.
101. Hynes R.O. The extracellular matrix: not just pretty fibrils. Science 2009, 326:1216-1219.
102. Im E., Kazlauskas A. Src family kinases promote vessel stability by antagonizing the Rho/ROCK pathway. J. Biol. Chem. 2007, 282:29122-29129.
103. Iruela-Arispe M.L., Davis G.E. Cellular and molecular mechanisms of vascular lumen formation. Dev. Cell 2009, 16:222-231.
104. Ispanovic E., Serio D., Haas T.L. Cdc42 and RhoA have opposing roles in regulating membrane type 1-matrix metalloproteinase localization and matrix metalloproteinase-2 activation. Am. J. Physiol. Cell Physiol. 2008, 295:C600-C610.
105. Itoh Y., Seiki M. MT1-MMP: an enzyme with multidimensional regulation. Trends Biochem. Sci. 2004, 29:285-289.
106. Jaffe A.B., Kaji N., Durgan J., Hall A. Cdc42 controls spindle orientation to position the apical surface during epithelial morphogenesis. J. Cell Biol. 2008, 183:625-633.
107. Jain R.K. Normalization of tumor vasculature: an emerging concept in antiangiogenic therapy. Science 2005, 307:58-62.
108. Jakobsson L., Domogatskaya A., Tryggvason K., Edgar D., Claesson-Welsh L. Laminin deposition is dispensable for vasculogenesis but regulates blood vessel diameter independent of flow. FASEB J. 2008, 22:1530-1539.
109. Kalen M., Wallgard E., Asker N., Nasevicius A., Athley E., Billgren E., et al. Combination of reverse and chemical genetic screens reveals angiogenesis inhibitors and targets. Chem. Biol. 2009, 16:432-441.
110. Kamei M., Saunders W.B., Bayless K.J., Dye L., Davis G.E., Weinstein B.M. Endothelial tubes assemble from intracellular vacuoles in vivo. Nature 2006, 442:453-456.
111. Kim Y.H., Hu H., Guevara-Gallardo S., Lam M.T., Fong S.Y., Wang R.A. Artery and vein size is balanced by Notch and ephrin B2/EphB4 during angiogenesis. Development 2008, 135:3755-3764.
112. Kiosses W.B., Hood J., Yang S., Gerritsen M.E., Cheresh D.A., Alderson N., et al. A dominant-negative p65 PAK peptide inhibits angiogenesis. Circ. Res. 2002, 90:697-702.
113. Kleaveland B., Zheng X., Liu J.J., Blum Y., Tung J.J., Zou Z., et al. Regulation of cardiovascular development and integrity by the heart of glass-cerebral cavernous malformation protein pathway. Nat. Med. 2009, 15:169-176.
114. Koh W., Mahan R.D., Davis G.E. Cdc42- and Rac1-mediated endothelial lumen formation requires Pak2, Pak4 and Par3, and PKC-dependent signaling. J. Cell Sci. 2008, 121:989-1001.
115. Koh W., Stratman A.N., Sacharidou A., Davis G.E. In vitro three dimensional collagen matrix models of endothelial lumen formation during vasculogenesis and angiogenesis. Methods Enzymol. 2008, 443:83-101.
116. Koh W., Sachidanandam K., Stratman A.N., Sacharidou A., Mayo A.M., Murphy E.A., et al. Formation of endothelial lumens requires a coordinated PKC{epsilon}-, Src-, Pak- and Raf-kinase-dependent signaling cascade downstream of Cdc42 activation. J. Cell Sci. 2009, 122:1812-1822.
117. Korff T., Augustin H.G. Integration of endothelial cells in multicellular spheroids prevents apoptosis and induces differentiation. J. Cell Biol. 1998, 143:1341-1352.
118. Korff T., Kimmina S., Martiny-Baron G., Augustin H.G. Blood vessel maturation in a 3-dimensional spheroidal coculture model: direct contact with smooth muscle cells regulates endothelial cell quiescence and abrogates VEGF responsiveness. FASEB J. 2001, 15:447-457.
119. Lafleur M.A., Handsley M.M., Knauper V., Murphy G., Edwards D.R. Endothelial tubulogenesis within fibrin gels specifically requires the activity of membrane-type-matrix metalloproteinases (MT-MMPs). J. Cell Sci. 2002, 115:3427-3438.
120. Lampugnani M.G., Dejana E. Adherens junctions in endothelial cells regulate vessel maintenance and angiogenesis. Thromb. Res. 2007, 120(Suppl. 2):S1-S6.
121. Lampugnani M.G., Orsenigo F., Rudini N., Maddaluno L., Boulday G., Chapon F., et al. CCM1 regulates vascular-lumen organization by inducing endothelial polarity. J. Cell Sci. 2010, 123:1073-1080.
122. Larina I.V., Shen W., Kelly O.G., Hadjantonakis A.K., Baron M.H., Dickinson M.E. A membrane associated mCherry fluorescent reporter line for studying vascular remodeling and cardiac function during murine embryonic development. Anat. Rec. (Hoboken) 2009, 292:333-341.
123. Lauer-Fields J.L., Juska D., Fields G.B. Matrix metalloproteinases and collagen catabolism. Biopolymers 2002, 66:19-32.
124. Lee S., Jilani S.M., Nikolova G.V., Carpizo D., Iruela-Arispe M.L. Processing of VEGF-A by matrix metalloproteinases regulates bioavailability and vascular patterning in tumors. J. Cell Biol. 2005, 169:681-691.
125. Lee P.F., Yeh A.T., Bayless K.J. Nonlinear optical microscopy reveals invading endothelial cells anisotropically alter three-dimensional collagen matrices. Exp. Cell Res. 2009, 315:396-410.
126. Leslie J.D., Ariza-McNaughton L., Bermange A.L., McAdow R., Johnson S.L., Lewis J. Endothelial signalling by the Notch ligand Delta-like 4 restricts angiogenesis. Development 2007, 134:839-844.
127. Li X.Y., Ota I., Yana I., Sabeh F., Weiss S.J. Molecular dissection of the structural machinery underlying the tissue-invasive activity of membrane type-1 matrix metalloproteinase. Mol. Biol. Cell 2008, 19:3221-3233.
128. Lilly B., Kennard S. Differential gene expression in a coculture model of angiogenesis reveals modulation of select pathways and a role for Notch signaling. Physiol. Genomics 2009, 36:69-78.
129. Liu Y., Senger D.R. Matrix-specific activation of Src and Rho initiates capillary morphogenesis of endothelial cells. FASEB J. 2004, 18:457-468.
130. Liu J., Fraser S.D., Faloon P.W., Rollins E.L., Vom Berg J., Starovic-Subota O., et al. A betaPix Pak2a signaling pathway regulates cerebral vascular stability in zebrafish. Proc. Natl. Acad. Sci. USA 2007, 104:13990-13995.
131. Liu H., Kennard S., Lilly B. NOTCH3 expression is induced in mural cells through an autoregulatory loop that requires endothelial-expressed JAGGED1. Circ. Res. 2009, 104:466-475.
132. Liu H., Rigamonti D., Badr A., Zhang J. Ccm1 regulates microvascular morphogenesis during angiogenesis. J. Vasc. Res. 2010, 48:130-140.
133. Lohela M., Bry M., Tammela T., Alitalo K. VEGFs and receptors involved in angiogenesis versus lymphangiogenesis. Curr. Opin. Cell Biol. 2009, 21:154-165.
134. Loo T.H., Ng Y.W., Lim L., Manser E. GIT1 activates p21-activated kinase through a mechanism independent of p21 binding. Mol. Cell. Biol. 2004, 24:3849-3859.
135. Lubarsky B., Krasnow M.A. Tube morphogenesis: making and shaping biological tubes. Cell 2003, 112:19-28.
136. Lucitti J.L., Jones E.A., Huang C., Chen J., Fraser S.E., Dickinson M.E. Vascular remodeling of the mouse yolk sac requires hemodynamic force. Development 2007, 134:3317-3326.
137. Macara I.G. Par proteins: partners in polarization. Curr. Biol. 2004, 14:R160-R162.
138. Madrid R., Aranda J.F., Rodriguez-Fraticelli A.E., Ventimiglia L., Andres-Delgado L., Shehata M., et al. The formin INF2 regulates basolateral-to-apical transcytosis and lumen formation in association with Cdc42 and MAL2. Dev. Cell 2010, 18:814-827.
139. Mancuso M.R., Davis R., Norberg S.M., O'Brien S., Sennino B., Nakahara T., et al. Rapid vascular regrowth in tumors after reversal of VEGF inhibition. J. Clin. Invest. 2006, 116:2610-2621.
140. Martin-Belmonte F., Gassama A., Datta A., Yu W., Rescher U., Gerke V., et al. PTEN-mediated apical segregation of phosphoinositides controls epithelial morphogenesis through Cdc42. Cell 2007, 128:383-397.
141. Martin-Belmonte F., Yu W., Rodriguez-Fraticelli A.E., Ewald A.J., Werb Z., Alonso M.A., et al. Cell-polarity dynamics controls the mechanism of lumen formation in epithelial morphogenesis. Curr. Biol. 2008, 18:507-513.
142. Martinez-Lemus L.A., Wu X., Wilson E., Hill M.A., Davis G.E., Davis M.J., et al. Integrins as unique receptors for vascular control. J. Vasc. Res. 2003, 40:211-233.
143. Mavria G., Vercoulen Y., Yeo M., Paterson H., Karasarides M., Marais R., et al. ERK-MAPK signaling opposes Rho-kinase to promote endothelial cell survival and sprouting during angiogenesis. Cancer Cell 2006, 9:33-44.
144. Mazzone M., Dettori D., Leite de Oliveira R., Loges S., Schmidt T., Jonckx B., et al. Heterozygous deficiency of PHD2 restores tumor oxygenation and inhibits metastasis via endothelial normalization. Cell 2009, 136:839-851.
145. McKinney M.C., Weinstein B.M. Chapter 4. Using the zebrafish to study vessel formation. Methods Enzymol. 2008, 444:65-97.
146. Miner J.H., Yurchenco P.D. Laminin functions in tissue morphogenesis. Annu. Rev. Cell Dev. Biol. 2004, 20:255-284.
147. Montero-Balaguer M., Swirsding K., Orsenigo F., Cotelli F., Mione M., Dejana E. Stable vascular connections and remodeling require full expression of VE-cadherin in zebrafish embryos. PLoS ONE 2009, 4:e5772.
148. Montesano R., Ghzili H., Carrozzino F., Rossier B.C., Feraille E. cAMP-dependent chloride secretion mediates tubule enlargement and cyst formation by cultured mammalian collecting duct cells. Am. J. Physiol. Renal Physiol. 2009, 296:F446-F457.
149. Nakatsu M.N., Hughes C.C. An optimized three-dimensional in vitro model for the analysis of angiogenesis. Methods Enzymol. 2008, 443:65-82.
150. Noguera-Troise I., Daly C., Papadopoulos N.J., Coetzee S., Boland P., Gale N.W., et al. Blockade of Dll4 inhibits tumour growth by promoting non-productive angiogenesis. Nature 2006, 444:1032-1037.
151. O'Brien L.E., Yu W., Tang K., Jou T.S., Zegers M.M., Mostov K.E. Morphological and biochemical analysis of Rac1 in three-dimensional epithelial cell cultures. Methods Enzymol. 2006, 406:676-691.
152. Ono Y., Nakanishi H., Nishimura M., Kakizaki M., Takahashi K., Miyahara M., et al. Two actions of frabin: direct activation of Cdc42 and indirect activation of Rac. Oncogene 2000, 19:3050-3058.
153. Orr A.W., Stockton R., Simmers M.B., Sanders J.M., Sarembock I.J., Blackman B.R., et al. Matrix-specific p21-activated kinase activation regulates vascular permeability in atherogenesis. J. Cell Biol. 2007, 176:719-727.
154. Ota I., Li X.Y., Hu Y., Weiss S.J. Induction of a MT1-MMP and MT2-MMP-dependent basement membrane transmigration program in cancer cells by Snail1. Proc. Natl. Acad. Sci. USA 2009, 106:20318-20323.
155. Peppiatt C.M., Howarth C., Mobbs P., Attwell D. Bidirectional control of CNS capillary diameter by pericytes. Nature 2006, 443:700-704.
156. Qi J.H., Ebrahem Q., Moore N., Murphy G., Claesson-Welsh L., Bond M., et al. A novel function for tissue inhibitor of metalloproteinases-3 (TIMP3): inhibition of angiogenesis by blockage of VEGF binding to VEGF receptor-2. Nat. Med. 2003, 9:407-415.
157. Qin Y., Meisen W.H., Hao Y., Macara I.G. Tuba, a Cdc42 GEF, is required for polarized spindle orientation during epithelial cyst formation. J. Cell Biol. 2010, 189:661-669.
158. Raffetto J.D., Khalil R.A. Matrix metalloproteinases and their inhibitors in vascular remodeling and vascular disease. Biochem. Pharmacol. 2008, 75:346-359.
159. Ramirez F., Dietz H.C. Extracellular microfibrils in vertebrate development and disease processes. J. Biol. Chem. 2009, 284:14677-14681.
160. Rhodes J.M., Simons M. The extracellular matrix and blood vessel formation: not just a scaffold. J. Cell. Mol. Med. 2007, 11:176-205.
161. Rodriguez-Fraticelli A.E., Vergarajauregui S., Eastburn D.J., Datta A., Alonso M.A., Mostov K., et al. The Cdc42 GEF Intersectin 2 controls mitotic spindle orientation to form the lumen during epithelial morphogenesis. J. Cell Biol. 2010, 189:725-738.
162. Rudini N., Felici A., Giampietro C., Lampugnani M., Corada M., Swirsding K., et al. VE-cadherin is a critical endothelial regulator of TGF-beta signalling. EMBO J. 2008, 27:993-1004.
163. Rupp P.A., Czirok A., Little C.D. Novel approaches for the study of vascular assembly and morphogenesis in avian embryos. Trends Cardiovasc. Med. 2003, 13:283-288.
164. Sabeh F., Shimizu-Hirota R., Weiss S.J. Protease-dependent versus -independent cancer cell invasion programs: three-dimensional amoeboid movement revisited. J. Cell Biol. 2009, 185:11-19.
165. Sacharidou A., Koh W., Stratman A.N., Mayo A.M., Fisher K.E., Davis G.E. Endothelial lumen signaling complexes control 3D matrix-specific tubulogenesis through interdependent Cdc42- and MT1-MMP-mediated events. Blood 2010, 115:5259-5269.
166. Sainson R.C., Aoto J., Nakatsu M.N., Holderfield M., Conn E., Koller E., et al. Cell-autonomous notch signaling regulates endothelial cell branching and proliferation during vascular tubulogenesis. FASEB J. 2005, 19:1027-1029.
167. San Antonio J.D., Zoeller J.J., Habursky K., Turner K., Pimtong W., Burrows M., et al. A key role for the integrin alpha2beta1 in experimental and developmental angiogenesis. Am. J. Pathol. 2009, 175:1338-1347.
168. Sato Y., Poynter G., Huss D., Filla M.B., Czirok A., Rongish B.J., et al. Dynamic analysis of vascular morphogenesis using transgenic quail embryos. PLoS ONE 2010, 5:e12674.
169. Saunders W.B., Bayless K.J., Davis G.E. MMP-1 activation by serine proteases and MMP-10 induces human capillary tubular network collapse and regression in 3D collagen matrices. J. Cell Sci. 2005, 118:2325-2340.
170. Saunders W.B., Bohnsack B.L., Faske J.B., Anthis N.J., Bayless K.J., Hirschi K.K., et al. Coregulation of vascular tube stabilization by endothelial cell TIMP-2 and pericyte TIMP-3. J. Cell Biol. 2006, 175:179-191.
171. Schiffrin E.L. Remodeling of resistance arteries in essential hypertension and effects of antihypertensive treatment. Am. J. Hypertens. 2004, 17:1192-1200.
172. Schulz B., Pruessmeyer J., Maretzky T., Ludwig A., Blobel C.P., Saftig P., et al. ADAM10 regulates endothelial permeability and T-Cell transmigration by proteolysis of vascular endothelial cadherin. Circ. Res. 2008, 102:1192-1201.
173. Segal S.S. Regulation of blood flow in the microcirculation. Microcirculation 2005, 12:33-45.
174. Sela S., Itin A., Natanson-Yaron S., Greenfield C., Goldman-Wohl D., Yagel S., et al. A novel human-specific soluble vascular endothelial growth factor receptor 1: cell-type-specific splicing and implications to vascular endothelial growth factor homeostasis and preeclampsia. Circ. Res. 2008, 102:1566-1574.
175. Senger D.R., Davis G.E. Angiogenesis. Cold Spring Harb. Perspect. Biol. 2010, (in press).
176. Senger D.R., Claffey K.P., Benes J.E., Perruzzi C.A., Sergiou A.P., Detmar M. Angiogenesis promoted by vascular endothelial growth factor: regulation through alpha1beta1 and alpha2beta1 integrins. Proc. Natl. Acad. Sci. USA 1997, 94:13612-13617.
177. Seo D.W., Li H., Guedez L., Wingfield P.T., Diaz T., Salloum R., et al. TIMP-2 mediated inhibition of angiogenesis: an MMP-independent mechanism. Cell 2003, 114:171-180.
178. Siekmann A.F., Lawson N.D. Notch signalling limits angiogenic cell behaviour in developing zebrafish arteries. Nature 2007, 445:781-784.
179. Smith M.L., Gourdon D., Little W.C., Kubow K.E., Eguiluz R.A., Luna-Morris S., et al. Force-induced unfolding of fibronectin in the extracellular matrix of living cells. PLoS Biol. 2007, 5:e268.
180. Somanath P.R., Ciocea A., Byzova T.V. Integrin and growth factor receptor alliance in angiogenesis. Cell Biochem. Biophys. 2009, 53:53-64.
181. Stetler-Stevenson W.G., Seo D.W. TIMP-2: an endogenous inhibitor of angiogenesis. Trends Mol. Med. 2005, 11:97-103.
182. Stockton R.A., Schaefer E., Schwartz M.A. p21-activated kinase regulates endothelial permeability through modulation of contractility. J. Biol. Chem. 2004, 279:46621-46630.
183. Strasser G.A., Kaminker J.S., Tessier-Lavigne M. Microarray analysis of retinal endothelial tip cells identifies CXCR4 as a mediator of tip cell morphology and branching. Blood 2010, 115:5102-5110.
184. Stratman A.N., Malotte K.M., Mahan R.D., Davis M.J., Davis G.E. Pericyte recruitment during vasculogenic tube assembly stimulates endothelial basement membrane matrix formation. Blood 2009, 114:5091-5101.
185. Stratman A.N., Saunders W.B., Sacharidou A., Koh W., Fisher K.E., Zawieja D.C., et al. Endothelial cell lumen and vascular guidance tunnel formation requires MT1-MMP-dependent proteolysis in 3-dimensional collagen matrices. Blood 2009, 114:237-247.
186. Stratman A.N., Schwindt A.E., Malotte K.M., Davis G.E. Endothelial-derived PDGF-BB and HB-EGF coordinately regulate pericyte recruitment during vasculogenic tube assembly and stabilization. Blood 2010, 116:4720-4730.
187. Strilic B., Kucera T., Eglinger J., Hughes M.R., McNagny K.M., Tsukita S., et al. The molecular basis of vascular lumen formation in the developing mouse aorta. Dev. Cell 2009, 17:505-515.
188. Stupack D.G., Cheresh D.A. Integrins and angiogenesis. Curr. Top. Dev. Biol. 2004, 64:207-238.
189. Su S.C., Mendoza E.A., Kwak H.I., Bayless K.J. Molecular profile of endothelial invasion of three-dimensional collagen matrices: insights into angiogenic sprout induction in wound healing. Am. J. Physiol. Cell Physiol. 2008, 295:C1215-C1229.
190. Su S.C., Maxwell S.A., Bayless K.J. Annexin 2 regulates endothelial morphogenesis by controlling AKT activation and junctional integrity. J. Biol. Chem. 2010.
191. Swendeman S., Mendelson K., Weskamp G., Horiuchi K., Deutsch U., Scherle P., et al. VEGF-A stimulates ADAM17-dependent shedding of VEGFR2 and crosstalk between VEGFR2 and ERK signaling. Circ. Res. 2008, 103:916-918.
192. Swift M.R., Weinstein B.M. Arterial-venous specification during development. Circ. Res. 2009, 104:576-588.
193. Tan W., Palmby T.R., Gavard J., Amornphimoltham P., Zheng Y., Gutkind J.S. An essential role for Rac1 in endothelial cell function and vascular development. FASEB J. 2008, 22:1829-1838.
194. ten Dijke P., Arthur H.M. Extracellular control of TGFbeta signalling in vascular development and disease. Nat. Rev. Mol. Cell Biol. 2007, 8:857-869.
195. Thomas M., Augustin H.G. The role of the Angiopoietins in vascular morphogenesis. Angiogenesis 2009, 12:125-137.
196. Thurston G., Rudge J.S., Ioffe E., Zhou H., Ross L., Croll S.D., et al. Angiopoietin-1 protects the adult vasculature against plasma leakage. Nat. Med. 2000, 6:460-463.
197. Thurston G., Noguera-Troise I., Yancopoulos G.D. The Delta paradox: DLL4 blockade leads to more tumour vessels but less tumour growth. Nat. Rev. Cancer 2007, 7:327-331.
198. Tian Y., Lei L., Cammarano M., Nekrasova T., Minden A. Essential role for the Pak4 protein kinase in extraembryonic tissue development and vessel formation. Mech. Dev. 2009, 126:710-720.
199. Tzima E., Irani-Tehrani M., Kiosses W.B., Dejana E., Schultz D.A., Engelhardt B., et al. A mechanosensory complex that mediates the endothelial cell response to fluid shear stress. Nature 2005, 437:426-431.
200. Ulmasov B., Bruno J., Gordon N., Hartnett M.E., Edwards J.C. Chloride intracellular channel protein-4 functions in angiogenesis by supporting acidification of vacuoles along the intracellular tubulogenic pathway. Am. J. Pathol. 2009, 174:1084-1096.
201. Uyttendaele H., Marazzi G., Wu G., Yan Q., Sassoon D., Kitajewski J. Notch4/int-3, a mammary proto-oncogene, is an endothelial cell-specific mammalian Notch gene. Development 1996, 122:2251-2259.
202. van den Akker J., Schoorl M.J., Bakker E.N., Vanbavel E. Small artery remodeling: current concepts and questions. J. Vasc. Res. 2010, 47:183-202.
203. van der Flier A., Badu-Nkansah K., Whittaker C.A., Crowley D., Bronson R.T., Lacy-Hulbert A., et al. Endothelial alpha5 and alphav integrins cooperate in remodeling of the vasculature during development. Development 2010, 137:2439-2449.
204. Vogel V. Mechanotransduction involving multimodular proteins: converting force into biochemical signals. Annu. Rev. Biophys. Biomol. Struct. 2006, 35:459-488.
205. Wagenseil J.E., Mecham R.P. Vascular extracellular matrix and arterial mechanics. Physiol. Rev. 2009, 89:957-989.
206. Wang H.U., Chen Z.F., Anderson D.J. Molecular distinction and angiogenic interaction between embryonic arteries and veins revealed by ephrin-B2 and its receptor Eph-B4. Cell 1998, 93:741-753.
207. Wang Y., Kaiser M.S., Larson J.D., Nasevicius A., Clark K.J., Wadman S.A., et al. Moesin1 and Ve-cadherin are required in endothelial cells during in vivo tubulogenesis. Development 2010, 137:3119-3128.
208. Warren C.M., Iruela-Arispe M.L. Signaling circuitry in vascular morphogenesis. Curr. Opin. Hematol. 2010, 17:213-218.
209. Whelan M.C., Senger D.R. Collagen I initiates endothelial cell morphogenesis by inducing actin polymerization through suppression of cyclic AMP and protein kinase A. J. Biol. Chem. 2003, 278:327-334.
210. Whitehead K.J., Chan A.C., Navankasattusas S., Koh W., London N.R., Ling J., et al. The cerebral cavernous malformation signaling pathway promotes vascular integrity via Rho GTPases. Nat. Med. 2009, 15:177-184.
211. Wojciak-Stothard B., Potempa S., Eichholtz T., Ridley A.J. Rho and Rac but not Cdc42 regulate endothelial cell permeability. J. Cell Sci. 2001, 114:1343-1355.
212. Yang S., Graham J., Kahn J.W., Schwartz E.A., Gerritsen M.E. Functional roles for PECAM-1 (CD31) and VE-cadherin (CD144) in tube assembly and lumen formation in three-dimensional collagen gels. Am. J. Pathol. 1999, 155:887-895.
213. Yaniv K., Isogai S., Castranova D., Dye L., Hitomi J., Weinstein B.M. Live imaging of lymphatic development in the zebrafish. Nat. Med. 2006, 12:711-716.
214. Zamir E.A., Czirok A., Cui C., Little C.D., Rongish B.J. Mesodermal cell displacements during avian gastrulation are due to both individual cell-autonomous and convective tissue movements. Proc. Natl. Acad. Sci. USA 2006, 103:19806-19811.
215. Zeeb M., Strilic B., Lammert E. Resolving cell-cell junctions: lumen formation in blood vessels. Curr. Opin. Cell Biol. 2010, 22:626-632.
216. Zhong C., Chrzanowska-Wodnicka M., Brown J., Shaub A., Belkin A.M., Burridge K. Rho-mediated contractility exposes a cryptic site in fibronectin and induces fibronectin matrix assembly. J. Cell Biol. 1998, 141:539-551.
217. Zhou Z., Apte S.S., Soininen R., Cao R., Baaklini G.Y., Rauser R.W., et al. Impaired endochondral ossification and angiogenesis in mice deficient in membrane-type matrix metalloproteinase I. Proc. Natl. Acad. Sci. USA 2000, 97:4052-4057.
218. Zhou X., Rowe R.G., Hiraoka N., George J.P., Wirtz D., Mosher D.F., et al. Fibronectin fibrillogenesis regulates three-dimensional neovessel formation. Genes Dev. 2008, 22:1231-1243.
219. Zhu W.H., Guo X., Villaschi S., Francesco Nicosia R. Regulation of vascular growth and regression by matrix metalloproteinases in the rat aorta model of angiogenesis. Lab. Invest. 2000, 80:545-555.
220. Zovein A.C., Alfonso Luque A., Turlo K.A., Hofmann J.J., Yee K.M., Becker M.S., et al. β1 integrin establishes endothelial cell polarity and arteriolar lumen formation via a Par3-dependent mechanism. Dev. Cell 2010, 18:39-51.